These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6629706)

  • 1. The immunologic and immunotherapeutic sequelae of intraperitoneal BCG. II: Serial changes in spleen weight, morphology, cell populations and in vitro mitogen responses.
    Roche WR; McLaughlin H
    Ir J Med Sci; 1983 Aug; 152(8):307-10. PubMed ID: 6629706
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the adjuvant effect of three BCG preparations in mice.
    Baker MA; Taub RN
    Oncology; 1978; 35(5):214-6. PubMed ID: 82928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.
    Mellow L; Sabbadini E
    Immunology; 1985 Oct; 56(2):235-43. PubMed ID: 2932383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposals for quality control methods of bacterial vaccines for immunostimulation. II. In vivo and in vitro stimulation of lymphocytes by BCG.
    Bruynzeel DP; Ettekoven H; Kreeftenberg JG
    Dev Biol Stand; 1977 Apr 13-15; 38():91-6. PubMed ID: 608553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of BCG vaccine on neoplastic proliferation and host immune responses.
    Hakim AA; Grand NG
    J Pharm Sci; 1976 Mar; 65(3):339-43. PubMed ID: 1263078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active suppression of in vitro reactivity of spleen cells after BCG treatment.
    Orbach-Arbouys S; Poupon MF
    Immunology; 1978 Mar; 34(3):431-7. PubMed ID: 305890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Nocardia-delipidated cell mitogen on intestinal mucosa and spleen lymphocytes of germ-free rats.
    Kozáková H; Stépánková R; Tlaskalová H; Barot-Ciorbaru R; Kolinská J
    Adv Exp Med Biol; 1995; 371A():483-7. PubMed ID: 8525972
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spleen reactivity after BCG treatement: test and strain dependency of the response].
    Florentin I; Orbach-Arbouys S
    Ann Immunol (Paris); 1977; 128(1-2):271-2. PubMed ID: 15497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early cellular responses to mitogens and adjuvants in the mouse spleen.
    Moatamed F; Karnovsky MJ; Unanue ER
    Lab Invest; 1975 Mar; 32(3):303-12. PubMed ID: 1079067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacillus Calmette-Guérin (BCG) decreases resistance to Listeria monocytogenes infection in mice.
    Wing EJ
    Immunology; 1981 Nov; 44(3):509-15. PubMed ID: 7319550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunologic and immunotherapeutic sequelae of intraperitoneal BCG. I: The local nature of immunostimulation and the effects of delayed-type hypersensitivity.
    Roche WR; McLaughlin H
    Ir J Med Sci; 1983 Aug; 152(8):303-6. PubMed ID: 6629705
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activation of the mononuclear phagocyte system by microbial stimulators].
    Maianskiĭ DN; Shcherbakov VI; Pravotorov GV
    Patol Fiziol Eksp Ter; 1983; (4):52-5. PubMed ID: 6634225
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo effects of dialyzable leukocyte lysates (DLL): changes in the responses of murine spleen cells to T-and B-cell mitogens, spleen weight, and morphology of splenic tissue.
    Huard TK; Sabet T; Baram P
    Clin Immunol Immunopathol; 1978 Oct; 11(2):229-44. PubMed ID: 737916
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant actions of polyclonal lymphocyte activators. III. Two distinct types of T-initiating adjuvant action demonstrated under different experimental conditions.
    Nakashima I; Nagase F; Matsuura A; Yokochi T; Kato N
    Cell Immunol; 1980 Jul; 52(2):429-37. PubMed ID: 7002322
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of lymphoid cells by BCG in vitro.
    Mokyr MB; Mitchell MS
    Cell Immunol; 1975 Feb; 15(2):264-73. PubMed ID: 1089480
    [No Abstract]   [Full Text] [Related]  

  • 16. Generation of anti-MOPC-315 cytotoxicity in uneducated or in vitro educated spleen cells from normal or MOPC-315 tumor-bearing mice pretreated in vivo with Bacillus Calmette-Guérin.
    Braun DP; Mokyr MB; Dray S
    Cancer Res; 1978 Jun; 38(6):1626-32. PubMed ID: 647676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulating effects of T-44.
    Kunze A; Langner J; Machulla HK; Peter W; Bekemeier H
    Agents Actions; 1991 Jan; 32(1-2):112-3. PubMed ID: 2058456
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of lymphocytes by lycorine-1-O-beta-D-glucoside.
    Chattopadhyay U; Chaudhuri L; Das S; Kumar Y; Ghosal S
    Pharmazie; 1984 Dec; 39(12):855-6. PubMed ID: 6531395
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence on immune function of mice by instillating BCG-PSN intravesically].
    Zhao XK; Qu XB; Wang YH
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):507-8. PubMed ID: 12212136
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible mechanism of the preventive effect of BCG against diabetes mellitus in NOD mouse. I. Generation of suppressor macrophages in spleen cells of BCG-vaccinated mice.
    Yagi H; Matsumoto M; Suzuki S; Misaki R; Suzuki R; Makino S; Harada M
    Cell Immunol; 1991 Nov; 138(1):130-41. PubMed ID: 1833072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.